Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Alembic Pharma secures USFDA nod for breast cancer drug Palbociclib

Ruchika Sharma9 Nov 2020 1:19 PM IST

Vadodara: Alembic Pharmaceuticals Limited today announced that the Company has received tentative approval from the US Food & Drug...

Biocon Biologics approves Rs 1,125 crore investment from Goldman Sachs

Ruchika Sharma9 Nov 2020 1:00 PM IST

As per the terms of the proposed agreement, Goldman Sachs will be issued Optionally Convertable Debentures at a post money equity valuation of USD...

Cipla prioritizes on Digital Adoption and resilient operations to achieve sustained Growth

Ruchika Sharma9 Nov 2020 12:22 PM IST

New Delhi: Pharma major Cipla is looking at sustaining growth through the pandemic and has decided certain priorities for the coming quarters,...

Pandemic opened up new opportunities for Indian Biotech sector: Kiran Mazumdar Shaw

Ruchika Sharma9 Nov 2020 11:15 AM IST

Hyderabad: The present global pandemic brought huge healthcare challenges but it has also opened up a huge number of opportunities for every part...

Glenmark reports net profit at Rs 234 crore in Q2

Ruchika Sharma9 Nov 2020 9:00 AM IST

New Delhi: Drug firm Glenmark Pharmaceuticals on Friday reported a consolidated net profit of Rs 233.99 crore for the second quarter ended...

Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026

Setback: Novartis arthritis drug Canakinumab fails to help Covid patients

Ruchika Sharma8 Nov 2020 11:00 AM IST

Zurich: Novartis's canakinumab failed to help Covid-19 patients survive without invasive ventilation compared with standard therapy, the Swiss...

Gland Pharma raises Rs 1,944 crore from anchor investors ahead of IPO

Ruchika Sharma8 Nov 2020 10:30 AM IST

New Delhi: Gland Pharma has raised Rs 1,944 crore from anchor investors ahead of its initial share-sale that opens for public subscription on...

Medical Device Industry: National Institute of Design, EEPC India collaborate to upgrade designs, technology

Ruchika Sharma8 Nov 2020 10:00 AM IST

New Delhi: Engineering exporters' body EEPC India and National Institute of Design on Friday joined hands to promote designs and technology for...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Novartis India reports net profit at Rs 7.52 crore in Q2

Ruchika Sharma8 Nov 2020 9:30 AM IST

New Delhi: Drug firm Novartis India on Thursday reported a net profit of Rs 7.52 crore for the second quarter ended September 30.The company had...

COVID-19: Argentina could receive 750,000 doses of vaccine from Pfizer

Ruchika Sharma8 Nov 2020 9:00 AM IST

Buenos Aires: Argentina President Alberto Fernandez said on Friday his country could receive 750,000 doses of an eventual coronavirus vaccine from...

Up to 90 percent price reduction seen in 526 brands of 42 anti cancer drugs: NPPA

Ruchika Sharma7 Nov 2020 3:33 PM IST

Based on the feedback received from the pharmaceutical companies after implementation of the NPPA notification, it was observed that under this...

Bharat Biotech Odisha unit to manufacture 10 types of vaccines

Ruchika Sharma7 Nov 2020 12:36 PM IST

The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhoea, Malaria, Japenese...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok